HbA1c变异性联合平均HbA1c预测中国2型糖尿病患者髋部骨折
本研究基于香港2008至2012年60岁及以上中国2型糖尿病患者电子健康记录,随访髋部骨折发生情况。结果显示,HbA1c变异性各指标均为髋部骨折的独立预测因子,校正风险比最高达1.29(均p<0.001),且在不同血糖控制强度组中均保持独立预测作用;平均HbA1c≥64 mmol/mol(8.0%)者髋部骨折风险较<53 mmol/mol(7.0%)者增加25%。
要点
- HbA1c变异性是2型糖尿病患者髋部骨折的独立预测因子,校正风险比最高1.29。
- HbA1c变异性在不同血糖控制强度组中均独立预测髋部骨折。
- 平均HbA1c≥64 mmol/mol(8.0%)者髋部骨折风险较<53 mmol/mol(7.0%)者增加25%。
核心结论
- HbA1c变异性是2型糖尿病患者髋部骨折的独立正向预测因子,且独立于平均HbA1c。
- 从骨骼健康角度,高HbA1c亦不可取。
研究设计与样本
- 基于香港2008至2012年电子健康记录,纳入60岁及以上中国2型糖尿病患者83,282例,随访髋部骨折发生。
- HbA1c变异性采用入组前5年HbA1c测量的标准差、校正标准差和变异系数确定。
- 采用多变量Cox回归分析评估HbA1c变异性与髋部骨折的关联。
主要发现
- 参与者平均年龄71.3±7.5岁,糖尿病病程11.7±7.7年,基线HbA1c 56.6±13.5 mmol/mol(7.33±1.23%),中位随访6.8年。
- HbA1c变异性所有指标均为髋部骨折的显著独立预测因子,校正风险比最高达1.29(均p<0.001)。
- HbA1c变异性在不同血糖控制强度组中均保持独立预测作用。
- 平均HbA1c≥64 mmol/mol(8.0%)者髋部骨折风险较平均HbA1c<53 mmol/mol(7.0%)者增加25%。
关键数值与推荐
- 髋部骨折定义采用国际疾病分类第九版(ICD-9)代码820。
- HbA1c变异性基于入组前5年HbA1c测量的标准差、校正标准差和变异系数。
- 平均HbA1c≥64 mmol/mol(8.0%)者髋部骨折风险较<53 mmol/mol(7.0%)者增加25%。
临床怎么用
- 在2型糖尿病管理中,除优化平均血糖外,应关注并尽量减少HbA1c变异性以利于骨骼健康。
- 对HbA1c变异性大的老年2型糖尿病患者,应加强髋部骨折风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Type 2 diabetes is associated with an increased risk of hip fractures. We hypothesize that long-term glycemic variability predicts incident hip fractures. We demonstrated that HbA1c variability predicted incident hip fractures independent of mean HbA1c, suggesting the potential benefits of minimizing glycemic variability in addition to optimizing mean glycemia for bone health. INTRODUCTION: Type 2 diabetes is associated with an increased risk of hip fractures, and a linear relationship between HbA1c levels and hip fracture incidence has been observed. We hypothesize that HbA1c variability also predicts incident hip fractures in type 2 diabetes. METHODS: Chinese individuals with type 2 diabetes aged ≥ 60 years were identified from electronic health records in Hong Kong between 2008 and 2012 and observed for incident hip fractures. Hip fracture was defined by the International Classification of Diseases (Ninth Revision) code 820. HbA1c variability was determined using standard deviation, adjusted standard deviation, and coefficient of variation of HbA1c measurements in the 5 years preceding the entry date. Multivariable Cox regression analysis was used to evaluate associations between HbA1c variability and incident hip fractures. RESULTS: A total of 83,282 participants were included. Their mean age was 71.3 ± 7.5 years, duration of diabetes 11.7 ± 7.7 years, baseline HbA1c 56.6 ± 13.5 mmol/mol (7.33 ± 1.23%), and median follow-up 6.8 years. All indices of HbA1c variability were significant independent predictors of incident hip fractures, with an adjusted hazard ratio of up to 1.29 (all p < 0.001), and remained to be independent predictors across groups of different intensity of glycemic control. Mean HbA1c ≥ 64 mmol/mol (8.0%) was associated with a 25% increase in incident hip fractures compared with mean HbA1c < 53 mmol/mol (7.0%). CONCLUSION: HbA1c variability is an independent positive predictor of hip fracture in type 2 diabetes, across the spectrum of varying degree of glycemic control, while a high HbA1c is also not advisable from the perspective of bone health.
引用
- Lui DTW, Lee CH, Chan YH, et al. HbA1c variability, in addition to mean HbA1c, predicts incident hip fractures in Chinese people with type 2 diabetes. Osteoporos Int. 2020. PMID: 32385660. doi:10.1007/s00198-020-05395-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。